[lbo-talk] Roger Morris on Rummy's Legacy

andie nachgeborenen andie_nachgeborenen at yahoo.com
Thu Feb 15 20:04:05 PST 2007


Undertaker's Tally part 1 http://www.truthout.org/docs_2006/021407E.shtml

a project of the Nation Institute --------------------------------------------------------------------------------

To send this to a friend, or to read more dispatches, go to tomdispatch.com Tomgram: Roger Morris, The Rumsfeld Legacy Here's a classic Rumsfeldism: "We do have a saying in America: if you're in a hole, stop digging ... erm, I'm not sure I should have said that." In Part 2 of his historical excavation of the life and world of Donald Rumsfeld (not to speak of the worlds of both President Bushes, the neocons, the U.S. military, the GOP, and an indolent media), Roger Morris, already deep in that hole, just keeps digging away. In doing so, he offers us the rest of Rumsfeld's long march to power, his lasting legacies, and the costly lessons of this comeback kid. So much that went unheeded in the years in which Rumsfeld once again scaled the heights of power is now, thanks to Morris, compactly on the record. "The absence of evidence is not necessarily the evidence of absence" is another infamous Rumsfeldism. How true. And in Rumsfeld's absence, the evidence of how he changed our world for the worse will be with us to consider for years to come. So, if you missed it, check out "Sharp Elbows," the first part of "The Undertaker's Tally," and then settle in for the sequel, the one you thought you knew until you read "The Power and the Glory." Read it and remember, the bell tolls for thee. Tom The Power and the Glory The Undertaker's Tally (Part 2) By Roger Morris In 1976, when Jimmy Carter took the Presidency from Gerald Ford, outgoing Defense Secretary Donald Rumsfeld went off to seek corporate wealth as head of G.D. Searle, a Skokie pharmaceutical company. His period running the business, inherited by the family of his North Shore friend and early backer Dan Searle, would become part of Rumsfeld's legend of success as a master manager, negligently accepted as fact by the media and Congressional representatives at his 2001 confirmation hearings. The legend went this way: Political prodigy slashes payroll 60%, turns decrepit loser into mega-profit-maker, earns industry kudos and multiple millions. In looking at men of prominence like Rumsfeld who revolve in and out of the private sector, the Washington media almost invariably adopts the press-release or booster business-page version of events from what inside-the-Beltway types call "the real world." In Rumsfeld's case, behind the image of corporate savior lay a far more relevant and ominous history. In the documented version of reality, derived from litigation and relatively obscure investigations in the U.S. and abroad, Searle turned out to enjoy its notable rise less thanks to Rumsfeldian innovative managerial genius than to old-fashioned reckless marketing of pharmaceuticals already on the shelf and the calling in of lobbying "markers" via its well-connected Republican CEO. And over it all wafted the distinctive odor of corrupt practices. A case in point was Searle's anti-diarrhea medicine Lomotil, sold ever more widely and profitably internationally (in industry terms "dumped") -- especially in Africa in the late 1970s -- despite the company's failure to warn of its potentially dire effects on younger children. "A blindly harmful stopcock," one medical journal called the remedy, which could be poisonous to infants only slightly above Searle's recommended dosage. Even taken according to directions, Lomotil was known to mask dangerous dehydration and cause a lethal build-up of fluids internally. Having advertised the medicine as "ideal for every situation," Searle did not undertake a cautionary labeling change until the end of 1981, nearly five years into Rumsfeld's tenure, and then only when threatened with damaging publicity by children's advocacy groups. Part of the vast outrage of multinational "pharmas" exploiting the Third World, the company under Rumsfeld would, like the more publicized Upjohn with its Depo-Provera, be implicated in widespread bribery of officials (and others) in poorer countries to promote the sale of oral contraceptives which had been found unsafe for American or European women. Click here to read more of this dispatch.

____________________________________________________________________________________ TV dinner still cooling? Check out "Tonight's Picks" on Yahoo! TV. http://tv.yahoo.com/



More information about the lbo-talk mailing list